97 related articles for article (PubMed ID: 10571158)
1. The synthesis and anti-MRSA activity of amidinium-substituted 2-dibenzofuranylcarbapenems.
Laub JB; Greenlee ML; DiNinno F; Huber JL; Sundelof JG
Bioorg Med Chem Lett; 1999 Oct; 9(20):2973-6. PubMed ID: 10571158
[TBL] [Abstract][Full Text] [Related]
2. New anti-MRSA and anti-VRE carbapenems; synthesis and structure-activity relationships of 1beta-methyl-2-(thiazol-2-ylthio)carbapenems.
Sunagawa M; Itoh M; Kubota K; Sasaki A; Ueda Y; Angehrn P; Bourson A; Goetschi E; Hebeisen P; Then RL
J Antibiot (Tokyo); 2002 Aug; 55(8):722-57. PubMed ID: 12374386
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological properties of a new series of anti-MRSA beta-lactams; 2-(thiazol-2-ylthio)carbapenems.
Shinagawa H; Yamaga H; Houchigai H; Sumita Y; Sunagawa M
Bioorg Med Chem; 1997 Mar; 5(3):601-21. PubMed ID: 9113338
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and SAR study of novel 7-(pyridinium-3-yl)-carbonyl imidazo[5,1-b]thiazol-2-yl carbapenems.
Maruyama T; Kano Y; Yamamoto Y; Kurazono M; Iwamatsu K; Atsumi K; Shitara E
Bioorg Med Chem; 2007 Jan; 15(1):392-402. PubMed ID: 17055731
[TBL] [Abstract][Full Text] [Related]
5. CP5484, a novel quaternary carbapenem with potent anti-MRSA activity and reduced toxicity.
Maruyama T; Yamamoto Y; Kano Y; Kurazono M; Matsuhisa E; Takata H; Takata T; Atsumi K; Iwamatsu K; Shitara E
Bioorg Med Chem; 2007 Oct; 15(19):6379-87. PubMed ID: 17681767
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of an anti-methicillin-resistant Staphylococcus aureus (MRSA) carbapenem via stannatrane-mediated Stille coupling.
Jensen MS; Yang C; Hsiao Y; Rivera N; Wells KM; Chung JY; Yasuda N; Hughes DL; Reider PJ
Org Lett; 2000 Apr; 2(8):1081-4. PubMed ID: 10804559
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antibacterial activity of 1beta-methyl-2-(5-substituted thiazolo pyrrolidin-3-ylthio)carbapenem derivatives.
Oh CH; Cho HW; Baek D; Cho JH
Eur J Med Chem; 2002 Sep; 37(9):743-54. PubMed ID: 12350291
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of novel di- and tricationic carbapenems with potent anti-MRSA activity.
Maruyama T; Yamamoto Y; Kano Y; Kurazono M; Shitara E; Iwamatsu K; Atsumi K
Bioorg Med Chem Lett; 2009 Jan; 19(2):447-50. PubMed ID: 19056265
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antibacterial activity of novel 4-pyrrolidinylthio carbapenems. Part III: Novel 2-alkyl substituents containing cationic heteroaromatics linked via a C-N bond.
Azami H; Barrett D; Matsuda K; Tsutsumi H; Washizuka K; Sakurai M; Kuroda S; Shirai F; Chiba T; Kamimura T; Murata M
Bioorg Med Chem; 1999 Aug; 7(8):1665-82. PubMed ID: 10482459
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel tricyclic carbapenems (trinems).
Kanno O; Shimoji Y; Ohya S; Kawamoto I
J Antibiot (Tokyo); 2000 Apr; 53(4):404-14. PubMed ID: 10866222
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of J-111,347, a novel 1 beta-methylcarbapenem with broad-spectrum antibacterial activity.
Imamura H; Ohtake N; Sakuraba S; Shimizu A; Yamada K; Morishima H
Chem Pharm Bull (Tokyo); 2000 Feb; 48(2):310-1. PubMed ID: 10705531
[TBL] [Abstract][Full Text] [Related]
12. Dicationic dithiocarbamate carbapenems with anti-MRSA activity.
Imamura H; Ohtake N; Jona H; Shimizu A; Moriya M; Sato H; Sugimoto Y; Ikeura C; Kiyonaga H; Nakano M; Nagano R; Abe S; Yamada K; Hashizume T; Morishima H
Bioorg Med Chem; 2001 Jun; 9(6):1571-8. PubMed ID: 11408176
[TBL] [Abstract][Full Text] [Related]
13. Dicationic 2-fluorenonylcarbapenems: potent anti-MRS agents with improved solubility and pharmacokinetic properties.
Greenlee ML; Laub JB; Rouen GP; DiNinno F; Hammond ML; Huber JL; Sundelof JG; Hammond GG
Bioorg Med Chem Lett; 1999 Nov; 9(22):3225-30. PubMed ID: 10576693
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin gallate synergistically enhances the activity of carbapenems against methicillin-resistant Staphylococcus aureus.
Hu ZQ; Zhao WH; Asano N; Yoda Y; Hara Y; Shimamura T
Antimicrob Agents Chemother; 2002 Feb; 46(2):558-60. PubMed ID: 11796378
[TBL] [Abstract][Full Text] [Related]
15. A practical and efficient preparation of the releasable naphthosultam side chain of a novel anti-MRSA carbapenem.
Miller RA; Humphrey GR; Lieberman DR; Ceglia SS; Kennedy DJ; Grabowski EJ; Reider PJ
J Org Chem; 2000 Mar; 65(5):1399-406. PubMed ID: 10814101
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems.
Imamura H; Ohtake N; Shimizu A; Sato H; Sugimoto Y; Sakuraba S; Nagano R; Nakano M; Abe S; Suzuki-Sato C; Nishimura I; Kojima H; Tsuchiya Y; Yamada K; Hashizume T; Morishima H
Bioorg Med Chem; 2000 Aug; 8(8):1969-82. PubMed ID: 11003142
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antibacterial evaluation of novel 2-[N-Imidoylpyrrolidinyl] carbapenems.
Hattori K; Yamada A; Kuroda S; Chiba T; Murata M; Sakane K
Bioorg Med Chem Lett; 2002 Feb; 12(3):383-6. PubMed ID: 11814802
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and activity of 2-(sulfonamido)methyl-carbapenems: discovery of a novel, anti-MRSA 1,8-naphthosultam pharmacophore.
Wilkening RR; Ratcliffe RW; Wildonger KJ; Cama LD; Dykstra KD; DiNinno FP; Blizzard TA; Hammond ML; Heck JV; Dorso KL; St Rose E; Kohler J; Hammond GG
Bioorg Med Chem Lett; 1999 Mar; 9(5):673-8. PubMed ID: 10201827
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and potent antibacterial activity against MRSA of some novel 1,2-disubstituted-1H-benzimidazole-N-alkylated-5-carboxamidines.
Göker H; Ozden S; Yildiz S; Boykin DW
Eur J Med Chem; 2005 Oct; 40(10):1062-9. PubMed ID: 15992965
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antibacterial activity of novel 4-pyrrolidinylthio carbapenems II: 2-alkyl and 2-arylthiomethyl derivatives.
Azami H; Matsuda K; Tsutsumi H; Kamimura T; Murata M
J Antibiot (Tokyo); 1998 Mar; 51(3):374-7. PubMed ID: 9589076
[No Abstract] [Full Text] [Related]
[Next] [New Search]
